Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2017, Article ID 9849425, 10 pages
https://doi.org/10.1155/2017/9849425
Clinical Study

Recurrent Stroke after Transcatheter PFO Closure in Cryptogenic Stroke or Tia: Long-Term Follow-Up

Pediatric Cardiology and GUCH Unit, S. Orsola-Malpighi Hospital, University of Bologna, 9 Massarenti Street, 40100 Bologna, Italy

Correspondence should be addressed to Elisabetta Mariucci; moc.liamg@iccuiramattebasile

Received 1 October 2017; Accepted 26 November 2017; Published 21 December 2017

Academic Editor: Antonis S. Manolis

Copyright © 2017 Elisabetta Mariucci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Writing Group Members, D. Mozaffarian, E. J. Benjamin et al., “Heart disease and stroke statistics—2016 update: a report from the American Heart Association,” Circulation, vol. 133, no. 4, pp. e38–e360, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. H. P. Adams, B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Publisher · View at Google Scholar
  3. R. G. Hart, H. C. Diener, S. B. Coutts et al., “Embolic strokes of undetermined source: the case for a new clinical construct,” The Lancet Neurology, vol. 13, no. 4, pp. 429–438, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J.-L. Mas, C. Arquizan, C. Lamy et al., “Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both,” New England Journal of Medicine, vol. 345, no. 24, pp. 1740–1746, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Almekhlafi, S. B. Wilton, D. M. Rabi, W. A. Ghali, D. L. Lorenzetti, and M. D. Hill, “Recurrent cerebral ischemia in medically treated patent foramen vale: a meta-analysis,” Neurology, vol. 73, no. 2, pp. 89–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Homma, M. R. DiTullio, R. L. Sacco, R. R. Sciacca, J. P. Mohr, and The PICSS Investigators, “Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale,” Stroke, vol. 35, no. 9, pp. 2145–2149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. D. Carroll, J. L. Saver, D. E. Thaler et al., “Closure of patent foramen ovale versus medical therapy after cryptogenic stroke,” New England Journal of Medicine, vol. 368, no. 12, pp. 1092–1100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Meier, B. Kalesan, H. P. Mattle et al., “Percutaneous closure of patent foramen ovale in cryptogenic embolism,” New England Journal of Medicine, vol. 368, no. 12, pp. 1083–1091, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Furlan, M. Reisman, J. Massaro et al., “Closure or medical therapy for cryptogenic stroke with patent foramen ovale,” New England Journal of Medicine, vol. 366, no. 11, pp. 991–999, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. N. W. Taggart, G. S. Reeder, R. J. Lennon et al., “Long-term follow-up after PFO device closure: outcomes and complications in a single-center experience,” Catheterization and Cardiovascular Interventions, vol. 89, no. 1, pp. 124–133, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. D. E. Thaler, R. Ruthazer, C. Weimar et al., “Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs,” Neurology, vol. 83, no. 3, pp. 221–226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Y. Lip, R. Nieuwlaat, R. Pisters, D. A. Lane, and H. J. Crijns, “Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation,” Chest, vol. 137, no. 2, pp. 263–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. B. de Vos, R. Pisters, R. Nieuwlaat et al., “Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis,” Journal of the American College of Cardiology, vol. 55, no. 8, pp. 725–731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. H. Eckman, D. E. Singer, J. Rosand, and S. M. Greenberg, “Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation,” Circulation: Cardiovascular Quality and Outcomes, vol. 4, no. 1, pp. 14–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. W. N. Kernan, B. Ovbiagele, H. R. Black et al., “Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 45, no. 7, pp. 2160–2236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. F. E. Silvestry, M. S. Cohen, L. B. Armsby et al., “Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions,” Journal of the American Society of Echocardiography, vol. 28, no. 8, pp. 910–958, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Jauss and E. Zanette, “Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography,” Cerebrovascular Diseases, vol. 10, no. 6, pp. 490–496, 2000. View at Publisher · View at Google Scholar
  18. E. K. Kerut, W. T. Norfleet, G. D. Plotnick, and T. D. Giles, “Patent foramen ovale: a review of associated conditions and the impact of physiological size,” Journal of the American College of Cardiology, vol. 38, no. 3, pp. 613–623, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. M. P. Spencer, M. A. Moehring, J. Jesurum, W. A. Gray, J. V. Olsen, and M. Reisman, “Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure,” Journal of Neuroimaging, vol. 14, no. 4, pp. 342–349, 2004. View at Publisher · View at Google Scholar
  20. S. Sastry, G. Riding, J. Morris et al., “Young adult myocardial infarction and ischemic stroke: the role of paradoxical embolism and thrombophilia (The YAMIS Study),” Journal of the American College of Cardiology, vol. 48, no. 4, pp. 686–691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Habib, P. Lancellotti, M. J. Antunes et al., “2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM),” European Heart Journal, vol. 36, no. 44, pp. 3075–3128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Baumgartner, P. Bonhoeffer, N. M. De Groot et al., “ESC guidelines for the management of grown-up congenital heart disease (new version 2010),” European Heart Journal, vol. 31, no. 23, pp. 2915–2957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Elmariah, A. J. Furlan, M. Reisman et al., “Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (evaluation of the STARFlex septal closure system in patients with a stroke and/or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale) trial,” JACC: Cardiovascular Interventions, vol. 7, no. 8, pp. 913–920, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Sanna, H. C. Diener, R. S. Passman et al., “Cryptogenic stroke and underlying atrial fibrillation,” New England Journal of Medicine, vol. 370, no. 26, pp. 2478–2486, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Gladstone, M. Spring, P. Dorian et al., “Atrial fibrillation in patients with cryptogenic stroke,” New England Journal of Medicine, vol. 370, no. 26, pp. 2467–2477, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Dussault, H. Toeg, M. Nathan, Z. J. Wang, J. F. Roux, and E. Secemsky, “Electrocardiographic monitoring for detecting atrial fibrillation after ischemic stroke or transient ischemic attack: systematic review and meta-analysis,” Circulation: Arrhythmia and Electrophysiology, vol. 8, no. 2, pp. 263–269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Kirchhof, S. Benussi, D. Kotecha et al., “2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC endorsed by the European Stroke Organisation (ESO),” European Heart Journal, vol. 37, no. 38, pp. 2893–2962, 2016. View at Publisher · View at Google Scholar · View at Scopus